Familial Nasopharyngeal Carcinoma 6

More documents

Recommendations

Info

Prognostic Factors in <strong>Nasopharyngeal</strong> Cancer 105Conventional antibody (VCA-IgG, EA-IgA, and EA-IgG)assays before treatment could not reflect the prognosis.After long-term follow-up, they also found that theposttreatment sequential measurements did not accuratelypredict the outcome (Neel and Taylor 1990). Amulticenter follow-up study on 319 NPC patientsshowed no prognostic values of initial serology, includingIgG and IgA antibodies to VCA, EA, or EBNA (deVathaire et al. 1988). However, increasing titers ofEA-IgA and EA-IgG, one year after completion ofAntibody Cutoff PFS OS CommentsEBV-MAEBV-MAEBV-MAVCA-IgAVCA-IgGEA-IgGvariousVCA-IgGEA-IgGVCA-IgAEA-IgAEBNA-IgGVCA-IgGEA-IgG³vs.
Page 2:
MEDICAL RADIOLOGYRadiation Oncology
Page 6:
Jiade J. Lu, MD, MBAAssociate Profe
Page 10:
PrefaceNasopharyngeal cancer is a u
Page 14:
Contents1 The Epidemiology of Nasop
Page 18:
The Epidemiology of Nasopharyngeal
Page 22:
Page 26:
Page 30:
Page 34:
10 M-S. Zeng and Y-X. Zengenvironme
Page 38:
12 M-S. Zeng and Y-X. Zengmedicinal
Page 42:
14 M-S. Zeng and Y-X. Zengloss and
Page 46:
16 M-S. Zeng and Y-X. ZengNPC sampl
Page 50:
18 M-S. Zeng and Y-X. Zengthe basal
Page 54:
20 M-S. Zeng and Y-X. Zengmultistep
Page 58:
22 M-S. Zeng and Y-X. ZengHui AB, L
Page 62:
24 M-S. Zeng and Y-X. ZengSnudden D
Page 66:
Molecular Signaling Pathways 3in Na
Page 70:
Molecular Signaling Pathways in Nas
Page 74:
Page 78:
Page 82:
Page 86:
Page 90:
Page 94:
Natural History, Presenting Symptom
Page 98:
Page 102:
Page 106:
Page 110:
Page 114:
Page 118:
54 P-J. Lou, W-L. Hsu, Y-C. Chien e
Page 122:
Page 126:
Page 130:
Page 134:
Page 138:
Page 142:
66 K. S. Lohobviously surmise that
Page 146:
68 K. S. LohTable 6.2. Causal assoc
Page 152:
Pathology of Nasopharyngeal Carcino
Page 156:
Page 160:
Page 164:
Page 168: Pathology of Nasopharyngeal Carcino
Page 172: Imaging in the Diagnosis and Stagin
Page 200: 96 J-C. Linon the outcome. The aim
Page 204: 98 J-C. LinTable 9.1. Summary of pr
Page 208: 100 J-C. LinTable 9.2. Summary of p
Page 212: 102 J-C. Lintumor volume was found
Page 216: 104 J-C. Lin(Neel et al. 1984a; Nee
Page 222: Prognostic Factors in Nasopharyngea
Page 270:
Prognostic Factors in Nasopharyngea
Page 274:
Page 278:
Page 282:
Early Stage Nasopharyngeal Cancer:
Page 286:
Page 290:
Page 294:
Page 298:
Page 302:
Page 306:
150 B. B. Y. Ma and A. T. C. Chan11
Page 310:
152 B. B. Y. Ma and A. T. C. Chanra
Page 314:
154 B. B. Y. Ma and A. T. C. ChanTa
Page 318:
156 B. B. Y. Ma and A. T. C. Chan20
Page 322:
158 B. B. Y. Ma and A. T. C. Channa
Page 326:
160 B. B. Y. Ma and A. T. C. ChanWa
Page 330:
162 J. S. Cooperdegree the failure
Page 334:
164 J. S. Cooperresources of the RT
Page 338:
166 J. S. CooperDimery IW, Peters L
Page 342:
168 J. Weemorbidity such as reduced
Page 346:
170 J. Weethey also took the opport
Page 350:
172 J. Weedisease-free survival rat
Page 354:
174 J. WeeTable 13.1. Randomized tr
Page 358:
176 J. Weesignificant improvements
Page 362:
178 J. WeeReferencesAdelstein DJ, S
Page 366:
180 J. Weenasopharyngeal carcinoma.
Page 370:
Neoadjuvant Chemotherapy: Trials 14
Page 374:
Neoadjuvant Chemotherapy: Trials an
Page 378:
Page 382:
Page 386:
Page 390:
Adjuvant Chemotherapy for Nasophary
Page 394:
Adjuvant Chemotherapy for Nasophary
Page 398:
Advances in the Technology of Radia
Page 402:
Page 406:
Page 410:
Page 414:
Page 418:
Page 422:
Page 426:
Page 430:
214 J. J. Lu, V. Grégoire, and S.
Page 434:
Page 438:
Page 442:
Page 446:
Page 450:
Page 454:
Page 458:
Page 462:
Page 466:
Page 470:
234 I. W. K. Tham and J. J. LuTable
Page 474:
236 I. W. K. Tham and J. J. Lu17% a
Page 478:
238 I. W. K. Tham and J. J. Lucompl
Page 482:
240 I. W. K. Tham and J. J. LuGan Y
Page 486:
242 D. Chua19.2Prognostic FactorsIm
Page 490:
244 D. Chuaglass. A plain X-ray of
Page 494:
246 D. ChuaTable 19.3. Results in l
Page 498:
248 D. Chuawas superior to nine-fie
Page 502:
250 D. ChuaChua DT, Sham JS, Kwong
Page 506:
Surgery for Recurrent Nasopharyngea
Page 510:
Page 514:
Page 518:
Page 522:
Page 526:
Page 530:
Page 534:
268 Y. Guo and B. S. Glissonpalliat
Page 538:
270 Y. Guo and B. S. Glissonresulti
Page 542:
272 Y. Guo and B. S. Glisson11.4 mo
Page 546:
274 Y. Guo and B. S. GlissonHasbini
Page 550:
276 S. S. Lo, J. J. Lu, and L. Kong
Page 554:
Page 558:
Page 562:
Page 566:
Page 570:
Page 574:
Page 578:
Page 582:
Page 586:
Page 590:
296 E. Ozyar and I. Ayanmetastasis,
Page 594:
298 E. Ozyar and I. Ayanmens (Lomba
Page 598:
300 E. Ozyar and I. Ayanchemotherap
Page 602:
302 E. Ozyar and I. AyanTable 23.1.
Page 606:
304 E. Ozyar and I. Ayanand 127 (96
Page 610:
306 E. Ozyar and I. Ayan(Hodgkin’
Page 614:
308 E. Ozyar and I. AyanChildren’
Page 618:
310 B. O’Sullivan and E. Yuthe ra
Page 622:
312 B. O’Sullivan and E. Yuin the
Page 626:
314 B. O’Sullivan and E. YuTable
Page 630:
316 B. O’Sullivan and E. YuFig. 2
Page 634:
318 B. O’Sullivan and E. Yudefine
Page 638:
320 B. O’Sullivan and E. YuFig. 2
Page 642:
322 B. O’Sullivan and E. YuLee CC
Page 646:
324 Subject Index- - hand-foot synd
Page 650:
326 Subject IndexInverse planning (
Page 654:
328 Subject IndexRadiosensitizer, 1
Page 658:
List of ContributorsRon R. Allison,
Page 662:
List of Contributors 333Shaojun Lin
Page 666:
Medical RadiologyDiagnostic Imaging
Page 670:
Medical RadiologyDiagnostic Imaging
show all

Familial Nasopharyngeal Carcinoma 6

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?